The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 82-93

  Dutra, Rafael C ^a   Bento, Allisson F ^a   Leite, Daniela F P ^a   Manjavachi, Marianne N ^a   Marcon, Rodrigo ^a   Bicca, Maíra Assunção ^a   Pesquero, João B ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; Bradykinin B1 and B2 receptors; Demyelination; EAE; Multiple sclerosis; Neuropathic pain

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; DES ARGININE LEUCINE BRADYKININ; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; ICATIBANT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE DELETION; GENE EXPRESSION; GLIA CELL; HYPERALGESIA; MOTOR COORDINATION; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION; SPINAL CORD; TACTILE STIMULATION; THERMAL STIMULATION; ANIMAL; C57BL MOUSE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; MOUSE; NEURALGIA; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURALGIA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2;

EID: 84875588590     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.02.007     Document Type: Article

References (63)

1. Bennett G.J. Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies?. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7737-7738.
2. Calixto J.B., et al. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 2004, 143:803-818.
3. Campos M.M., et al. Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol. Sci. 2006, 27:646-651.
4. Canton A., et al. Type 1 diabetes mellitus in Catalonia: chronic complications and metabolic control ten years after onset. Med. Sci. Monit. 2004, 10:CR185-CR190.
5. Cohen J., Wilkin G.P. Neural Cell Culture: a Practical Approach 1995, IRL Press, Oxford.
6. Costa R., et al. Anti-nociceptive effect of kinin B(1) and B(2) receptor antagonists on peripheral neuropathy induced by paclitaxel in mice. Br. J. Pharmacol. 2011, 164:681-693.
7. Cunha T.M., et al. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur. J. Pharmacol. 2007, 573:221-229.
8. de Lago E., et al. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacology 2012, 62:2299-2308.
9. DeLeo J.A., Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001, 90:1-6.
10. Dos Santos A.C., et al. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J. Neuroinflammation 2008, 5:49.
11. Dutra R.C., et al. The Role of Kinin Receptors in Preventing Neuroinflammation and Its Clinical Severity during Experimental Autoimmune Encephalomyelitis in Mice. PLoS One 2011, 6:e27875.
12. Ferreira J., et al. Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J. Neurosci. 2005, 25:2405-2412.
13. Ferretti S., et al. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003, 170:2106-2112.
14. Fujita M., et al. Roles of kinin B1 and B2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice. Eur. J. Pain 2010, 14:588-594.
15. Gao Y.J., Ji R.R. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7:482-493.
16. Gao Y.J., et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J. Neurosci. 2009, 29:4096-4108.
17. Gerard C., Rollins B.J. Chemokines and disease. Nat. Immunol. 2001, 2:108-115.
18. Germain L., et al. Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis. J. Neurol. Sci. 1988, 83:211-217.
19. Gobel K., et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J. Autoimmun. 2011, 36:106-114.
20. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
21. Hald A., et al. Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. Eur. J. Pain 2009, 13:138-145.
22. Heblich F., et al. Indirect actions of bradykinin on neonatal rat dorsal root ganglion neurones: a role for non-neuronal cells as nociceptors. J. Physiol. 2001, 536:111-121.
23. Hosli L., et al. Colocalization of receptors for vasoactive peptides on astrocytes of cultured rat spinal cord and brain stem: electrophysiological effects of atrial and brain natriuretic peptide, neuropeptide Y and bradykinin. Neurosci. Lett. 1992, 148:114-116.
24. Ibrahim S.M., et al. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 2001, 124:1927-1938.
25. Kim C.F., Moalem-Taylor G. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J. Pain 2010, 12:370-383.
26. Lock C., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
27. Marceau F., Bachvarov D.R. Kinin receptors. Clin. Rev. Allergy Immunol. 1998, 16:385-401.
28. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
29. McMahon S.B., et al. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 2005, 192:444-462.
30. Meotti F., et al. Inflammatory muscle pain is dependent on the activation of kinin B(1) and B(2) receptors and intracellular kinase pathways. Br. J. Pharmacol. 2012, 166:1127-1139.
31. Molet S., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 2001, 108:430-438.
32. Nair A., et al. Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 2008, 65:2702-2720.
33. Noda M., et al. Expression and function of bradykinin receptors in microglia. Life Sci. 2003, 72:1573-1581.
34. O'Connor A.B., et al. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 2008, 137:96-111.
35. Olechowski C.J., et al. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 2009, 141:156-164.
36. Olson J.K. Immune response by microglia in the spinal cord. Ann. N. Y. Acad. Sci. 2010, 1198:271-278.
37. Osterberg A., Boivie J. Central pain in multiple sclerosis - sensory abnormalities. Eur. J. Pain 2010, 14:104-110.
38. Osterberg A., et al. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur. J. Pain 2005, 9:531-542.
39. Pesquero J.B., et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8140-8145.
40. Polomano R.C., Bennett G.J. Chemotherapy-evoked painful peripheral neuropathy. Pain Med. 2001, 2:8-14.
41. Prat A., et al. Kinin B1 receptor expression and function on human brain endothelial cells. J. Neuropathol. Exp. Neurol. 2000, 59:896-906.
42. Prat A., et al. Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability. Arch. Neurol. 2005, 62:795-800.
43. Quintao N.L., et al. The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice. Anesth. Analg. 2005, 101:1763-1769.
44. Quintao N.L., et al. Neuropathic pain-like behavior after brachial plexus avulsion in mice: the relevance of kinin B1 and B2 receptors. J. Neurosci. 2008, 28:2856-2863.
45. Raghavendra V., et al. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 2004, 20:467-473.
46. + channels and Gi/o protein in the antinociceptive action of the gallic acid ethyl ester. Eur. J. Pharmacol. 1999, 379:7-17.
47. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
48. Schulze-Topphoff U., et al. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat. Med. 2009, 15:788-793.
49. Seltzer Z., et al. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43:205-218.
50. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
51. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007, 13:139-145.
52. Stromnes I.M., Goverman J.M. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 2006, 1:1810-1819.
53. Stromnes I.M., et al. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008, 14:337-342.
54. Svendsen K.B., et al. Pain in patients with multiple sclerosis: a population-based study. Arch. Neurol. 2003, 60:1089-1094.
55. Talbot S., et al. Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin. J. Neuroinflammation 2009, 6:11.
56. Talbot S., et al. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy. J. Neuroinflammation 2010, 7:36.
57. Tracey D.J., Walker J.S. Pain due to nerve damage: are inflammatory mediators involved?. Inflamm. Res. 1995, 44:407-411.
58. Tzartos J.S., et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
59. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
60. Wei F., et al. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J. Neurosci. 2008, 28:10482-10495.
61. Werner M.F., et al. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology 2007, 53:48-57.
62. Zhang R.X., et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 2005, 118:125-136.
63. Zhuang Z.Y., et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 2006, 26:3551-3560.